Long-term efficacy, safety, and patient acceptability of ibandronate in the treatment of postmenopausal osteoporosis.

Int J Womens Health · 2015 · PMC4274146 · PMID 25565901

Europe PMC DOI

hedged sentence

0.0560

closest p · 1.1× alpha

0.0560

boldest claim

The sentences

a nonsignificant trendP =0.056so close (0.05 < p ≤ 0.1)

There was a nonsignificant trend with 59% reduction in VFs as early as 1 year ( P =0.056).

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.